Article Details
Retrieved on: 2024-05-01 11:43:50
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article addresses the clinical development of CD70-targeting therapies in biotech, highlighting their promise in immunotherapy for cancer treatment. With over 20 therapies in trials, various approaches like monoclonal antibodies, ADCs, and CAR T-cell therapy are explored, aiming to leverage the immune system’s T cells against malignancies. Biopharmaceutical advances are key.
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here